Healthcare Sector

PFE

Market Tracker

$25.67
-0.81
(-3.05%)
7:00 pm
Next Earnings: (est.) 11/02/22 12:00 am
  • PFE (Selected)

    Pfizer Inc.
  • PFEB

    Innovator S&P 500 Power Buffer ETF - February

PFE Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

PFE Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

PFE Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

PFE Dark Pool and Public Equity Key Price Levels

Loading Data..

Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.

PFE Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

PFE Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
01/15/2027 CALL $27.00 50,529 +3,604 +7.68%
05/08/2026 CALL $26.50 17,091 +3,187 +22.92%
01/15/2027 PUT $23.00 40,510 +3,146 +8.42%
12/18/2026 CALL $27.00 18,690 +2,167 +13.12%
05/15/2026 CALL $26.50 6,771 +2,061 +43.76%
06/11/2026 CALL $27.46 1,900 +1,900
12/18/2026 CALL $20.00 489 -1,544 -75.95%
05/15/2026 CALL $26.00 1,845 -2,103 -53.27%
05/08/2026 CALL $25.00 23 -2,265 -98.99%
01/15/2027 CALL $20.00 5,015 -3,897 -43.73%
05/08/2026 CALL $26.00 590 -4,351 -88.06%
06/18/2026 CALL $23.00 833 -5,111 -85.99%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

PFE Major Holders

Name Pct Held Shares Total
Vanguard Total Stock Market Index Fund 2.94% 165.24M 7.61B
Vanguard 500 Index Fund 2.21% 124.19M 5.72B
Washington Mutual Investors Fund 1.35% 76.03M 3.5B
Income Fund of America Inc 1.13% 63.51M 2.92B
SPDR S&P 500 ETF Trust 1.07% 60.16M 2.77B
Fidelity 500 Index Fund 1.06% 59.56M 2.74B
American Balanced Fund 1.06% 59.6M 2.74B
Vanguard Specialized-Health Care Fund 0.99% 55.6M 2.56B
iShares Core S&P 500 ETF 0.89% 49.69M 2.29B
Vanguard Index-Value Index Fund 0.86% 48.52M 2.23B
Vanguard Institutional Index Fund-Institutional Index Fund 0.74% 41.57M 1.91B
Vanguard/Wellington Fund Inc. 0.64% 36.07M 1.66B
Vanguard Fenway Funds-Equity Income Fund 0.58% 32.43M 1.49B
MFS Series Trust I-MFS Value Fund 0.53% 29.66M 1.37B
Fundamental Investors Inc 0.48% 27.19M 1.25B

PFE News

  • Could Buying This Beaten-Down Healthcare Stock Make You Rich If It Recovers?

    05/09 12:15 pm

    The Motley Fool

    Read more
  • 3 Healthcare Stocks Every Retiree Should Consider

    05/08 07:15 pm

    The Motley Fool

    Read more
  • Will Eli Lilly Be the First $2 Trillion Healthcare Stock? 3 Catalysts That Could Get It There.

    05/08 09:30 am

    The Motley Fool

    Read more
  • History Suggests These 3 Stocks Are Due for a Major Rebound

    05/06 07:15 pm

    The Motley Fool

    Read more
  • Pfizer Says Vyndamax Drug Patent Settlement Reshapes Post-2028 Revenue View

    05/05 12:15 pm

    Benzinga

    Read more
  • Arvinas to Report First Quarter 2026 Financial Results on May 12, 2026

    05/05 07:00 am

    GlobeNewswire Inc.

    Read more
  • Pfizer, Arvinas Win FDA Nod For First-Of-Its-Kind Breast Cancer Therapy

    05/04 12:30 pm

    Benzinga

    Read more
  • Eli Lilly Just Announced Fantastic News for Shareholders

    05/04 05:05 am

    The Motley Fool

    Read more
  • Pfizer Stock: Still Priced Like It's Dead Money

    05/03 07:15 pm

    The Motley Fool

    Read more
  • Arvinas Announces FDA Approval of VEPPANU (vepdegestrant) for the Treatment of ESR1m, ER+/HER2- Advanced Breast Cancer

    05/01 12:43 pm

    GlobeNewswire Inc.

    Read more
  • Should You Forget This High-Yield Pharma Stock and Buy a Growth Name Instead?

    04/30 03:10 am

    The Motley Fool

    Read more
  • Pfizer Says Cancer Therapy Beats Standard Therapy In Late-Stage Blood Cancer Study

    04/29 02:41 pm

    Benzinga

    Read more
  • Retatrutide Crosses the Surgical Threshold, but the Real Race Has Just Started

    04/29 11:00 am

    GlobeNewswire Inc.

    Read more
  • Dietary Supplements Market Driven by Health and Nutrition Demand

    04/29 03:31 am

    GlobeNewswire Inc.

    Read more
  • Antibiotic Resistance Market to Grow at 5.4% CAGR Reaching USD 12.72 Billion by 2031, Driven by Rising Drug-Resistant Infections and Antimicrobial Innovation: Mordor Intelligence

    04/28 03:52 am

    GlobeNewswire Inc.

    Read more
  • Stock Market Today, April 27: Organon Shares Surge After Sun Pharma Agrees to Acquire Company in All Cash Deal

    04/27 05:34 pm

    The Motley Fool

    Read more
  • AI Disruption in Lung Cancer Therapeutics Set to Transform Treatment Paradigms as Billion-Dollar Investments Drive Innovation

    04/27 01:36 pm

    GlobeNewswire Inc.

    Read more
  • Peripheral T-Cell Lymphoma Market to Witness Significant Expansion at a CAGR of 7% During the Forecast Period (2026–2036) Amid Advancing Treatment Landscape | DelveInsight

    04/27 01:00 pm

    GlobeNewswire Inc.

    Read more
  • Relay Therapeutics Announces Clinical Data for Zovegalisib plus Atirmociclib Triplet Combination Supportive of Further Development in Frontline Metastatic Breast Cancer

    04/27 06:00 am

    GlobeNewswire Inc.

    Read more
  • Is This Tech Giant the Next Potential Winner in the GLP-1 Weight Loss Boom?

    04/25 01:05 pm

    The Motley Fool

    Read more
  • TACO Trade Joke No More? Trump's Art Of The Deal' Powers S&P 500's Steepest Highs And Lows

    04/24 07:31 am

    Benzinga

    Read more
  • Levicept to Present Data from Phase II study of LEVI-04 at OARSI 2026 World Congress on Osteoarthritis

    04/24 04:00 am

    GlobeNewswire Inc.

    Read more
  • Chronic Obstructive Pulmonary Disease Clinical Trial Landscape Expands: Over 65 Companies Advancing Next-Generation Therapies | DelveInsight

    04/23 01:00 pm

    GlobeNewswire Inc.

    Read more
  • Large Drugmakers Eye Inhibrx Cancer Drugs Valued Over $8 Billion, Stock Surges

    04/22 02:20 pm

    Benzinga

    Read more
  • Nurix Therapeutics Announces New Preclinical Data Highlighting Breadth of Targeted Protein Degradation Pipeline at AACR 2026

    04/22 07:00 am

    GlobeNewswire Inc.

    Read more
  • A Monthly Weight Loss Shot? Why Pfizer Could Topple Lilly's and Novo's GLP-1 Duopoly

    04/21 07:30 am

    The Motley Fool

    Read more
  • Bispecific Antibody Market Landscape Report 2026: A Potential $60 Opportunity by 2031 - Insight on More than 550 Clinical Trials - Antibody Dosage, Patent, Price, Sales & Outlook

    04/21 04:34 am

    GlobeNewswire Inc.

    Read more
  • This Drug Stock Has Crushed the S&P 500 Over the Last Decade

    04/18 05:15 pm

    The Motley Fool

    Read more
  • Non-Small Cell Lung Cancer Clinical Trial Race Intensifies as 100+ Companies Competing in Therapeutic Segment Worldwide | DelveInsight

    04/16 01:00 pm

    GlobeNewswire Inc.

    Read more
  • Investing $8,000 In Each of These 3 Stocks in 2026 Could Generate $1,500 in Annual Dividends

    04/14 09:30 am

    The Motley Fool

    Read more
  • $5.14 Bn Castration-sensitive Prostate Cancer Market Insights, Epidemiology, and Forecasts, 2022-2026 & 2026-2036

    04/13 04:44 am

    GlobeNewswire Inc.

    Read more
  • Atopic Dermatitis (7MM) Drug Market Forecast and Analysis Report 2023-2033: Opportunities Remain for the Treatment of AD, Novel Systemic Therapies Dominate the Late-stage Pipeline

    04/10 04:52 am

    GlobeNewswire Inc.

    Read more
  • Atopic Dermatitis 68-Market Drug Forecast and Market Analysis Report 2023-2025 & 2025-2033

    04/10 04:46 am

    GlobeNewswire Inc.

    Read more
  • Crohn's Disease Eight-Market Drug Forecast and Market Analysis Report 2025-2026: Novel MOAs Will Provide Market Shifts Throughout the Forecast Period to 2032

    04/10 04:43 am

    GlobeNewswire Inc.

    Read more
  • Serina Therapeutics to Present at the 5th LNP Formulation & Process Development Summit

    04/07 06:00 am

    GlobeNewswire Inc.

    Read more
  • Trump Imposes 100% Drug Tariffs: 5 Pharma Stocks That Won’t Pay a Dime

    04/06 01:20 pm

    Investing.com

    Read more
  • Déclaration d'actions et de droits de vote de la société Valneva SE - Mars 2026

    04/03 02:30 am

    GlobeNewswire Inc.

    Read more
  • Declaration of shares and voting rights of Valneva SE – March 2026

    04/03 02:30 am

    GlobeNewswire Inc.

    Read more
  • 3 Monster Dividend Stocks to Hold for the Next 10 Years

    04/02 05:15 am

    The Motley Fool

    Read more
  • Trump Administration Prepares 100% Tariffs On Drugmakers Without Pricing Deals: Report

    04/02 04:44 am

    Benzinga

    Read more
  • Esophageal Cancer Market to Grow from $1.65 Billion in 2026 to $2.37 Billion by 2030: Pfizer, Roche, Merck & Co. Dominate

    03/30 05:00 am

    GlobeNewswire Inc.

    Read more
  • Prediction: Buying Pfizer Stock Today Could Set You Up for Life

    03/29 08:15 pm

    The Motley Fool

    Read more
  • 1 Reason This Biotech Stock Could Triple Before Year-End

    03/29 12:30 am

    The Motley Fool

    Read more
  • Could Buying Eli Lilly Today Set You Up for Life?

    03/26 03:15 pm

    The Motley Fool

    Read more
  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Valneva SE – VALN

    03/24 05:49 pm

    GlobeNewswire Inc.

    Read more
  • Serina Therapeutics to Present at the 38th Annual Roth Conference

    03/24 06:00 am

    GlobeNewswire Inc.

    Read more
  • Valneva-Pfizer Lyme Shot Stumbles Yet Keeps Regulatory Path Alive

    03/23 10:35 am

    Benzinga

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: